References
- Kremer J. M., Lee J. K. A long‐term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of 53 month. Arthritis Rheum 1988; 31: 577–84
- Freeman‐Narrod M., Gerstley B. J., Engstrom P. F. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer 1975; 36: 1619–24
- Hamilton R. A., Kremer J. M. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol 1997; 36: 86–90
- Wegrzyn J., Adeleine P., Miossec P. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1232–4
- Bingham S. J., Buch H., Lindsay S., Pollard A., White J., Emery P. Parenteral methotrexate should be given before biological therapy. Rheumatology 2003; 42: 1009–10
- Osman A., Mulherin D. Is parenteral methotrexate worth trying?. Ann Rheum Dis 2001; 60: 432
- Burbage G., Gupta R., Lim K. Intramuscular methotrexate in inflammatory rheumatic disease. Ann Rheum Dis 2001; 60: 1156
- Erkeller‐Yuksel F. M., Griffin A. J. Parenteral methotrexate really works. Ann Rheum Dis 2003; 61((Suppl 1))209
- Rozin A., Schapira D., Balbir‐Gurman A., Braun‐Moscovici Y., Markovits D., Militianu D., et al. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate. Ann Rheum Dis 2002; 61: 756–7
- Maetzel A., Wong A., Strand V., Tugwell P., Wells G., Bombardier C. Meta‐analysis of treatment termination rates among rheumatoid arthritis patients receiving disease‐modifying anti‐rheumatic drugs. Rheumatology 2000; 39: 975–81